Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

L. E. M. Oosten*, M. E. D. Chamuleau, F. W. Thielen, L. C. de Wreede, C. Siemes, J. K. Doorduijn, O. S. Smeekes, M. J. Kersten, L. Hardi, J. W. Baars, A. M. P. Demandt, W. B. C. Stevens, M. Nijland, G. W. van Imhoff, R. Brouwer, C. A. Uyl-de Groot, P. M. Kluin, D. de Jong, H. Veelken

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)255-266
Number of pages12
JournalAnnals of Hematology
Volume97
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Burkitt lymphoma
  • Drugtherapy
  • Survival
  • Cost nalysis
  • B-CELL LYMPHOMA
  • ALLOGENEIC TRANSPLANTATION
  • RESPONSE CRITERIA
  • CODOX-M/IVAC
  • LEUKEMIA
  • RITUXIMAB
  • COSTS
  • MULTICENTER
  • NETHERLANDS
  • PROTOCOLS

Cite this